Univest
Univest
  • Markets

Godavari Drugs Ltd. (GODAVARI) Share Price Rise Streak: Second Straight Session, Up 20.23%

  • October 9, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Godavari Drugs Ltd. Share Price Rise Streak
Godavari Drugs Ltd. (GODAVARI) share price rose to Rs 141.45 today, up 9.52% from the previous close. Market cap was Rs 140.96 crore.

Godavari Drugs Ltd. Share Price is trading higher in its second straight session, with the latest traded price at Rs 141.45 after a 20.23% cumulative rise across the streak from Rs 117.65. According to Univest data, the price pattern is confirmed, but no company-specific catalyst is established.

Godavari Drugs Ltd. Share Price now reflects a market capitalisation of Rs 140.96 Cr, so the move should be read as a two-session pattern rather than a one-day gain. For readers tracking Godavari Drugs Ltd. Share Price Today, the key point is that consecutive higher sessions can change the short-term reading of the stock even when the broader business metrics stay unchanged. Univest is useful here because it lets investors place the streak beside valuation, sector position and peer context without turning the move into a prediction.

Table of Contents

Toggle
  • Godavari Drugs Ltd. Share Price Rise Streak: Consecutive Gain Analysis
  • What the Consecutive Gains Show
  • Godavari Drugs Ltd. (GODAVARI) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching Godavari Drugs Ltd.
  • About Godavari Drugs Ltd.
  • Frequently Asked Questions
    • Why is Godavari Drugs Ltd. Share Price rising today?
    • What does the 20.23% streak in Godavari Drugs Ltd. Share Price mean?
    • What is the latest price of Godavari Drugs Ltd. Share Price today?
    • How did Godavari Drugs Ltd. Share Price trade during the day?
    • What is the market capitalisation of Godavari Drugs Ltd. Share Price?
    • How does Godavari Drugs Ltd. Share Price look on valuation?
    • How does Godavari Drugs Ltd. compare with the same-industry benchmark?
    • How does Godavari Drugs Ltd. compare with peers?
  • Track Godavari Drugs Ltd. Share Price on Univest

Godavari Drugs Ltd. Share Price Rise Streak: Consecutive Gain Analysis

For readers following Godavari Drugs Ltd. Share Price Today, the streak matters because it shows a sequence of rising sessions rather than one isolated move. The company’s market capitalisation stands at Rs 140.96 Cr, which places the move in a clear company-size context while leaving fundamentals unchanged across the streak. Univest tracks this kind of price rise by linking today’s move to valuation, sector positioning and peer comparison, so the focus stays on verified numbers rather than conjecture.

Godavari Drugs Ltd. (GODAVARI) rose to Rs 141.45 from the previous close of Rs 129.15, a move of Rs 12.3 or 9.52%. The stock opened at Rs 125.6, reached a high of Rs 141.9, recorded a low of Rs 125.6.

Godavari Drugs Ltd. Share Price Today shows a firm intraday rise, with the latest traded price at Rs 141.45 versus the previous close of Rs 129.15. The stock moved up Rs 12.30, or 9.52%, and stayed above the day open of Rs 125.60. It touched a high of Rs 141.90 and a low of Rs 125.60 during the move.

Godavari Drugs Ltd. Share Price therefore sat near the upper end of the day’s range, with the latest traded price just below the session high. That matters for price action because it shows where the stock is trading relative to the day’s own band, not relative to a forecast. The market capitalisation of Rs 140.96 Cr gives the move scale, but not a quality judgement. In Univest framing, the important point is simple: Godavari Drugs Ltd. Share Price is rising today, and the session adds another higher leg to the streak. The next section looks at what that consecutive pattern shows.

What the Consecutive Gains Show

Godavari Drugs Ltd. Share Price is now in a second straight session of gains, and the full streak has added 20.23% from Rs 117.65. That cumulative move is the main differentiator from a one-session price rise because it shows the stock is being repriced across two trading days rather than only one. Univest data confirms the pattern, but it does not establish why the sequence continued.

For readers of Godavari Drugs Ltd. Share Price News and Godavari Drugs Ltd. Share Price Live updates, the useful question is not whether the move is large, but how the two sessions compare. The first move created the base, and the second straight session carried the latest traded price to Rs 141.45. That is why the streak matters in share price analysis: it changes the visible pattern on the screen and gives investors a cleaner point for stock analysis than a single-day jump alone. Univest presents the move as a verified streak, not as a forecast.

Godavari Drugs Ltd. (GODAVARI) Fundamental Analysis

Metric Value
Market Capitalisation Rs 140.96 crore
P/E Ratio 33.92x
P/B Ratio 1.79x
ROE 10.64%
ROCE 10.13%
EPS Rs 3.81
Book Value Per Share Rs 72.07
Dividend Yield 0%

Godavari Drugs Ltd. (GODAVARI) fundamental metrics show P/E 33.92x, P/B 1.79x, ROE 10.64%, ROCE 10.13%. Read together, these ratios describe the company’s position rather than a recommendation.

Godavari Drugs Ltd. has a market capitalisation of Rs 140.96 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 33.92x, P/B at 1.79x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 10.64% and ROCE of 10.13%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 3.81, book value per share of Rs 72.07, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.28x, median ROE of 11.61%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Pharmaceuticals & Drugs
Benchmark Scope same industry
Company P/E Ratio 33.92x
Benchmark Median P/E 31.28x
Benchmark Average P/E 47.09x
Benchmark P/E Range 3.56x to 678.22x
Company P/B Ratio 1.79x
Benchmark Median P/B 2.85x
Company ROE 10.64%
Benchmark Median ROE 11.61%
Company ROCE 10.13%
Benchmark Median ROCE 13.46%
Company Market Capitalisation Rs 140.96 crore
Benchmark Median Market Cap Rs 821.44 crore

Godavari Drugs Ltd. (GODAVARI) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Godavari Drugs Ltd. (GODAVARI) has a P/E ratio of 33.92x, which is above the benchmark median of 31.28x, a difference of +8.44%. The P/E comparison frames valuation; it is not a signal to buy or sell.

Godavari Drugs Ltd. (GODAVARI) has a ROE of 10.64%, which is below the benchmark median of 11.61%, a difference of -8.35%. Godavari Drugs Ltd. (GODAVARI) has a ROCE of 10.13%, which is below the benchmark median of 13.46%, a difference of -24.74%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Sun Pharmaceutical Industries Ltd. SUNPHARMA 4,27,861.41 34.76 4.86 14.85 19.11
Divi's Laboratories Ltd. DIVISLAB 2,54,318.9 85.21 14.11 16.19 21.51
Torrent Pharmaceuticals Ltd. TORNTPHARM 1,79,153.26 81.53 19.81 26.76 19.27
Zydus Lifesciences Ltd. ZYDUSLIFE 1,15,111.94 24.65 4.13 19.69 21.39
Laurus Labs Ltd. LAURUSLABS 1,11,034.16 98.83 19.16 18.31 18.2

Godavari Drugs Ltd. (GODAVARI) has a P/E ratio of 33.92x compared with the displayed peer median of 81.53x. Peer multiples give relative context only, not a buy or sell view. Its ROE of 10.64% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 10.13% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Godavari Drugs Ltd. (GODAVARI) has a market capitalisation of Rs 140.96 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Godavari Drugs Ltd.

  • Godavari Drugs Ltd. Share Price is in a second straight session of gains, and the cumulative streak move stands at 20.23% from Rs 117.65.
  • The latest traded price of Rs 141.45 is near the day high of Rs 141.90, which makes the intraday price action worth tracking.
  • The P/E of 33.92 now sits above the same-industry median, so Godavari Drugs Ltd. Share Price needs valuation context after the rise.
  • The P/B of 1.79 remains below the industry median of 2.85, keeping the book-value relationship relevant for stock analysis.
  • Univest places Godavari Drugs Ltd. Share Price beside sector and peer benchmarks, which helps readers read the move without assuming a cause.

About Godavari Drugs Ltd.

Godavari Drugs Ltd. operates in the Pharmaceuticals & Drugs industry within Healthcare, and that business context matters when reading Godavari Drugs Ltd. Share Price. The company’s current market capitalisation is Rs 140.96 Cr, so the stock is being viewed in the context of a smaller listed healthcare name rather than a sector heavyweight. For a streak-based read, the main takeaway is that the price move has altered the market view faster than the operating base has changed.

Godavari Drugs Ltd. Share Price should therefore be interpreted with its business profile in mind. The company belongs to a sector where earnings quality, capital efficiency and valuation all matter, and Univest uses the same structure to keep the share price rise linked to fundamentals. With EPS at Rs 3.81, book value at Rs 72.07 and ROE at 10.64%, the business snapshot helps explain why the market is looking at the stock through both price and financial ratios. That is the practical lens for understanding the streak.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

Why is Godavari Drugs Ltd. Share Price rising today?

Ans. Godavari Drugs Ltd. Share Price is rising in a second straight session, with the latest traded price at Rs 141.45 and a 9.52% move today. Univest data confirms the move itself, though no company-specific trigger has been identified.

What does the 20.23% streak in Godavari Drugs Ltd. Share Price mean?

Ans. The 20.23% cumulative move shows that Godavari Drugs Ltd. Share Price has risen across two consecutive sessions, not just one trading day. The streak started from Rs 117.65 and now places the stock at Rs 141.45.

What is the latest price of Godavari Drugs Ltd. Share Price today?

Ans. Godavari Drugs Ltd. Share Price last traded at Rs 141.45 on 09 October 2026 at 2:52:44 PM IST. The stock was up Rs 12.30, or 9.52%, from the previous close of Rs 129.15.

How did Godavari Drugs Ltd. Share Price trade during the day?

Ans. Godavari Drugs Ltd. Share Price opened at Rs 125.60, touched a high of Rs 141.90 and a low of Rs 125.60. The latest traded price sat close to the session high, which is useful for price action reading.

What is the market capitalisation of Godavari Drugs Ltd. Share Price?

Ans. Godavari Drugs Ltd. Share Price has a market capitalisation of Rs 140.96 Cr. That places the move in company-size context, while the streak itself remains a price event rather than a statement about business quality.

How does Godavari Drugs Ltd. Share Price look on valuation?

Ans. Godavari Drugs Ltd. Share Price is trading at a P/E of 33.92 and a P/B of 1.79. After the streak, the earnings and book-value base is unchanged, so the valuation multiple has moved mainly because the price moved.

How does Godavari Drugs Ltd. compare with the same-industry benchmark?

Ans. Godavari Drugs Ltd. Share Price has a P/E above the same-industry median of 31.28 and a P/B below the median of 2.85. ROE of 10.64% and ROCE of 10.13% are both below the benchmark medians.

How does Godavari Drugs Ltd. compare with peers?

Ans. Godavari Drugs Ltd. Share Price has a smaller market capitalisation than the listed peers in this comparison set and a lower P/B than each peer shown. Its P/E sits below several expensive peers but above some value-oriented names.

Track Godavari Drugs Ltd. Share Price on Univest

Use Godavari Drugs Ltd. (GODAVARI) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Investors can track Godavari Drugs Ltd. Share Price on Univest for the latest traded price, valuation ratios, market capitalisation, 52-week levels and market insights in one place. That makes it easier to follow Godavari Drugs Ltd. Share Price Today alongside the company’s fundamental analysis and sector comparison.

For a stock that is rising in a second straight session, Univest also helps readers keep the share price rise in context with peer numbers and healthcare benchmarks. Godavari Drugs Ltd. Share Price Live monitoring is especially useful when the move is being driven by price action rather than a confirmed company-specific trigger.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply